| Schedule of Income Tax (Expense) Benefit |
The
(provision) benefit from income taxes for the years ended December 31, 2021 and 2020 consists of the following:
Schedule of Income Tax (Expense) Benefit
| |
|
2021 |
|
|
2020 |
|
| Current |
|
|
|
|
|
|
|
|
| Federal |
|
$ |
(14,860 |
) |
|
$ |
1,373,348 |
|
| State |
|
|
(164,670 |
) |
|
|
(65,168 |
) |
| |
|
|
(179,530 |
) |
|
|
1,308,180 |
|
| |
|
|
|
|
|
|
|
|
| Deferred |
|
|
|
|
|
|
|
|
| Federal |
|
|
- |
|
|
|
- |
|
| State |
|
|
- |
|
|
|
- |
|
| |
|
|
- |
|
|
|
- |
|
| |
|
|
|
|
|
|
|
|
| (Provision) benefit from income taxes |
|
$ |
(179,530 |
) |
|
$ |
1,308,180 |
|
|
| Schedule of Effective Income Tax Rate Reconciliation |
The
following reconciles the Federal statutory income tax rate to the Company’s effective tax rate for the years ended December 31,
2021 and 2020:
Schedule of Effective Income Tax Rate Reconciliation
| |
|
2021 |
|
|
2020 |
|
| |
|
% |
|
|
% |
|
| Federal statutory rate |
|
|
21.0 |
|
|
|
21.0 |
|
| Permanent and other items |
|
|
0.6 |
|
|
|
(2.0 |
) |
| Federal income taxes audit and other adjustments |
|
|
63.5 |
|
|
|
2.5 |
|
| Change in valuation allowance |
|
|
(81.6 |
) |
|
|
(14.6 |
) |
| Effective income tax rate |
|
|
3.5 |
|
|
|
6.9 |
|
|
| Schedule of Deferred Tax Assets and Liabilities |
Deferred
tax assets and liabilities are comprised of the following at December 31, 2021 and 2020:
Schedule of Deferred Tax Assets and Liabilities
| |
|
2021 |
|
|
2020 |
|
| Deferred income tax assets: |
|
|
|
|
|
|
|
|
| Amortization |
|
$ |
460,537 |
|
|
$ |
586,174 |
|
| Net operating loss carryforward |
|
|
15,164,992 |
|
|
|
20,671,683 |
|
| Allowance for doubtful accounts |
|
|
401,436 |
|
|
|
403,991 |
|
| Charitable contributions |
|
|
644 |
|
|
|
624 |
|
| Stock options |
|
|
1,003,453 |
|
|
|
971,860 |
|
| Accrued liabilities |
|
|
1,711,890 |
|
|
|
312,419 |
|
| HHS Provider Relief Funds |
|
|
- |
|
|
|
1,175,790 |
|
| Employee retention credit |
|
|
292,282 |
|
|
|
- |
|
| R&D credit carryforward |
|
|
- |
|
|
|
220,431 |
|
| VisualMed Basis Difference |
|
|
878,709 |
|
|
|
- |
|
| Deferred state tax asset |
|
|
3,683,024 |
|
|
|
5,117,347 |
|
| Total deferred income tax
assets |
|
|
23,596,967 |
|
|
|
29,460,319 |
|
| |
|
|
|
|
|
|
|
|
| Deferred income tax liabilities: |
|
|
|
|
|
|
|
|
| Depreciation |
|
|
(691,456 |
) |
|
|
(1,498,698 |
) |
| Deferred tax asset, net |
|
|
22,905,511 |
|
|
|
27,961,621 |
|
| |
|
|
|
|
|
|
|
|
| Less: valuation allowance |
|
|
(22,905,511 |
) |
|
|
(27,961,621 |
) |
| |
|
|
|
|
|
|
|
|
| Net deferred tax assets |
|
$ |
- |
|
|
$ |
- |
|
|